The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.
Open accessAbstract
Tumors express peptide antigens capable of being recognized by tumor-specific cytotoxic T lymphocytes (CTL). Immunization of mice with a carcinogen-induced colorectal tumor, CT26, engineered to secrete granulocyte/macrophage colony-stimulating factor, routinely generated both short-term and long-term CTL lines that not only lysed the parental tumor in vitro, but also cured mice of established tumor following adoptive transfer in vivo. When either short-term or long-term CTL lines were used to screen peptides isolated from CT26, one reverse-phase high performance liquid chromatography peptide fraction consistently sensitized a surrogate target for specific lysis. The bioactivity remained localized within one fraction following multiple purification procedures, indicating that virtually all of the CT26-specific CTL recognized a single peptide. This result contrasts with other tumor systems, where multiple bioactive peptide fractions have been detected. The bioactive peptide was identified as a nonmutated nonamer derived from the envelope protein (gp70) of an endogenous ecotropic murine leukemia provirus. Adoptive transfer with CTL lines specific for this antigen demonstrated that this epitope represents a potent tumor rejection antigen. The selective expression of this antigen in multiple non-viral-induced tumors provides evidence for a unique class of shared immunodominant tumor associated antigens as targets for antitumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Self-citationProtein sequencing by tandem mass spectrometry.
Hunt, D. F., Yates, J. R., Shabanowitz, J., Winston, S., & Hauer, C. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6233 · Cited by 1,180
Self-citationA p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Brichard, V, Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., & Boon, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.489 · Cited by 950
Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., & Frost, P. (1990) · Cell · doi:10.1016/0092-8674(90)90591-2 · Cited by 916
Self-citationCoulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Slingluff, C. L. (1994) · Science · doi:10.1126/science.7513441 · Cited by 824
Self-citationIsolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., & Rammensee, H.-G. (1990) · Nature · doi:10.1038/348252a0 · Cited by 769
Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M., & Pardoll, D. M. (1991) · Science · doi:10.1126/science.1948050 · Cited by 719
Self-citationA new class of murine leukemia virus associated with development of spontaneous lymphomas.
Hartley, J. W., Wolford, N. K., Old, L. J., & Rowe, W. P. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.789 · Cited by 710
Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule
Bleek, G. M. V., & Nathenson, S. G. (1990) · Nature · doi:10.1038/348213a0 · Cited by 679
Corbett, T. H., Griswold, D. P., Roberts, B. J., Peckham, J. C., & Schabel, F. M. (1975) · PubMed · Cited by 584
Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., & Boon, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7976 · Cited by 423
Ono, M., Yasunaga, T., Miyata, T., & Ushikubo, H. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.589-598.1986 · Cited by 332
Lurquin, C., Van Pel, A., Mariamé, B., De Plaen, E., Szikora, J.-P., Janssens, C., Reddehase, M. J., Lejeune, J., & Boon, T. (1989) · Cell · doi:10.1016/0092-8674(89)90844-1 · Cited by 300
The development of a method for the preparation of rat intestinal epithelial cell primary cultures
Evans, G. S., Flint, N., Somers, A. S., Eyden, B., & Potten, C. S. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.1.219 · Cited by 298
Van den Eynde, B., Lethé, B., Van Pel, A., De Plaen, E., & Boon, T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1373 · Cited by 298
Udaka, K., Tsomides, T. J., & Eisen, H. N. (1992) · Cell · doi:10.1016/0092-8674(92)90617-l · Cited by 274
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma
Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., & Eisenbach, L. (1994) · Nature · doi:10.1038/369067a0 · Cited by 254
DeLeo, A. B., Shiku, H., Takahashi, T., John, M., & Old, L. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.3.720 · Cited by 222
Ono, M., Kawakami, M., & Ushikubo, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.2059-2062.1987 · Cited by 214
Sauter, M., Schommer, S., Kremmer, E., Remberger, K., Dölken, G., Lemm, I., Buck, M., Best, B., Neumann-Haefelin, D., & Mueller-Lantzsch, N. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.414-421.1995 · Cited by 212
Sykulev, Y., Brunmark, A., Tsomides, T. J., Kageyama, S., Jackson, M., Peterson, P. A., & Eisen, H. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11487 · Cited by 194
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
Levitsky, H. I., Lazenby, A., Hayashi, R. J., & Pardoll, D. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1215 · Cited by 189
Self-citationMandelboim, O., Vadai, E., Fridkin, M., Katz-Hillel, A., Feldman, M., Berke, G., & Eisenbach, L. (1995) · Nature Medicine · doi:10.1038/nm1195-1179 · Cited by 163
Ono, M. (1986) · Journal of Virology · doi:10.1128/jvi.58.3.937-944.1986 · Cited by 156
Medstrand, P., & Blomberg, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6778-6787.1993 · Cited by 154
Corr, M., Boyd, L. F., Frankel, S. R., Kozlowski, S., PADLAN, E. A., & Margulies, D. H. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1681 · Cited by 143
Storkus, W. J., Zeh, H. J., Maeurer, M. J., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3719 · Cited by 139
Nucleotide Sequence of the Akv env Gene
Lenz, J., Crowther, R. L., Straceski, A. J., & Haseltine, W. A. (1982) · Journal of Virology · doi:10.1128/jvi.42.2.519-529.1982 · Cited by 138
Slingluff, C. L., Cox, A. L., Henderson, R. A., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2955 · Cited by 122
A novel human nonviral retroposon derived from an endogenous retrovirus
Ono, M., Kawakami, M., & Takezawa, T. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.21.8725 · Cited by 95
ENDOGENOUS MOUSE LEUKEMIA VIRUSES
Risser, R., Horowitz, J. M., & McCubrey, J. A. (1983) · Annual Review of Genetics · doi:10.1146/annurev.ge.17.120183.000505 · Cited by 73
Schulz, M., Aichele, P., Schneider, R., Hansen, T. H., Zinkernagel, R. M., & Hengartner, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210513 · Cited by 65
Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains.
Chen, Y. T., Obata, Y., Stockert, E., & Old, L. J. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.4.1134 · Cited by 45
Matis, L. A., Ruscetti, S. K., Longo, D. L., Jacobson, S., Brown, E. J., Zinn, S., & Kruisbeek, A. M. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.1.703 · Cited by 43
Faff, O., Murray, A. B., Schmidt, J., Leib‐Mösch, C., Erfle, V., & Hehlmann, R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-5-1087 · Cited by 43
Adoptive chemoimmunotherapy of murine leukemia with helper T lymphocyte clones.
Bookman, M. A., Swerdlow, R. H., & Matis, L. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3166 · Cited by 38
Hayashi, H., Matsubara, H., Yokota, T., Kuwabara, I., Kanno, M., Koseki, H., Isono, K., ASANO, T., & Taniguchi, M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1223 · Cited by 37
Tsomides, T. J., & Eisen, H. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3487 · Cited by 26
Iezzi, G., Protti, M. P., Rugarli, C., & Bellone, M. (1996) · PubMed · Cited by 23
Effects of tumor growth on host defenses
Cianciolo, G. J., & D, R. S. M. (1986) · Cancer and Metastasis Reviews · doi:10.1007/bf00049528 · Cited by 19
Chemotherapy of large intestinal carcinoma. Current results and future prospects
Schein, P. S., Kisner, D. L., & Macdonald, J. S. (2006) · Cancer · doi:10.1002/1097-0142(197512)36:6<2441::aid-cncr2820360627>3.0.co;2-p · Cited by 19
Cited by
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Self-citationCD91 Is a Common Receptor for Heat Shock Proteins gp96, hsp90, hsp70, and Calreticulin
Basu, S., Binder, R. J., Ramalingam, T., & Srivastava, P. K. (2001) · Immunity · doi:10.1016/s1074-7613(01)00111-x · Cited by 900
Metadata
- Authors
- Huang, A. Y., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C. D., Wang, W., Engelhard, V. H., Pasternack, G., Cotter, R., Hunt, D., Pardoll, D. M., & Jaffee, E. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-09-03
- Volume
- 93
- Issue
- 18
- Pages
- 9730-9735
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2149118203
- Cited by
- 388
- References
- 45
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.